The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease
Alba Di Pardo(Istituto Neurologico Mediterraneo), Annibale Alessandro Puca(University of Salerno)
Cited by 27
Related Papers
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
|Scientific Reports|2017|78
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
|Frontiers in Neuroscience|2018|77